ASX Value Picks ALS And Two More Stocks Estimated Below Intrinsic Value
As the Australian market braces for a soft opening amid global tensions and fluctuating oil prices, investors are keenly observing the impact of these developments on local indices. In such a climate, identifying stocks that are trading below their intrinsic value can present opportunities for those looking to capitalize on potential market inefficiencies.
Top 10 Undervalued Stocks Based On Cash Flows In Australia
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Telix Pharmaceuticals (ASX:TLX) | A$15.62 | A$27.85 | 43.9% |
| Symal Group (ASX:SYL) | A$2.79 | A$5.56 | 49.8% |
| Superloop (ASX:SLC) | A$3.06 | A$5.61 | 45.4% |
| ReadyTech Holdings (ASX:RDY) | A$1.585 | A$2.78 | 43% |
| PolyNovo (ASX:PNV) | A$1.07 | A$1.96 | 45.5% |
| Nuix (ASX:NXL) | A$1.425 | A$2.67 | 46.7% |
| Mesoblast (ASX:MSB) | A$2.36 | A$4.19 | 43.7% |
| Elsight (ASX:ELS) | A$5.90 | A$10.77 | 45.2% |
| Bellevue Gold (ASX:BGL) | A$1.66 | A$3.31 | 49.9% |
| Aroa Biosurgery (ASX:ARX) | A$0.57 | A$0.99 | 42.4% |
Let's take a closer look at a couple of our picks from the screened companies.
ALS (ASX:ALQ)
Overview: ALS Limited provides professional technical and analytical services focused on testing, measurement, and inspection across regions including Africa, Asia Pacific, Europe, the Middle East, North Africa, and the United States with a market capitalization of A$11.24 billion.
Operations: The company's revenue is derived from two main segments: Commodities, contributing A$1.29 billion, and Life Sciences, generating A$2.03 billion.
Estimated Discount To Fair Value: 18.9%
ALS, trading at A$22.14, is undervalued compared to its estimated future cash flow value of A$27.29. Although earnings are forecasted to grow at 12.29% annually, the company carries a high debt load and has seen significant insider selling recently. Revenue growth is expected to outpace the Australian market slightly at 6.4%. Recent index inclusions in S&P International 700 and S&P Global 1200 highlight its growing market presence despite executive changes.
- The analysis detailed in our ALS growth report hints at robust future financial performance.
- Navigate through the intricacies of ALS with our comprehensive financial health report here.
Inghams Group (ASX:ING)
Overview: Inghams Group Limited operates in the production and sale of chicken and turkey products under the Ingham’s brand, serving markets primarily in Australia and New Zealand, with a market cap of A$765.66 million.
Operations: The company generates revenue of A$3.23 billion from its Feed and Poultry Industry segment, focusing on chicken and turkey products in Australia and New Zealand.
Estimated Discount To Fair Value: 11.8%
Inghams Group, trading at A$2.06, is slightly undervalued relative to its estimated future cash flow value of A$2.34. While earnings are projected to grow significantly at 21.5% annually, profit margins have decreased from 2.8% to 1.1%. Recent earnings show net income fell to A$34.6 million from A$89.8 million last year, and interest payments are not well covered by current earnings levels despite high forecasted return on equity in three years (30%).
- Our expertly prepared growth report on Inghams Group implies its future financial outlook may be stronger than recent results.
- Click here to discover the nuances of Inghams Group with our detailed financial health report.
Temple & Webster Group (ASX:TPW)
Overview: Temple & Webster Group Ltd operates as an online retailer specializing in furniture, homewares, and home improvement products in Australia, with a market cap of A$501.15 million.
Operations: The company's revenue primarily comes from the sale of furniture, homewares, and home improvement products, totaling A$664.59 million.
Estimated Discount To Fair Value: 39%
Temple & Webster Group is trading at A$4.3, notably undervalued against its estimated future cash flow value of A$7.05, presenting a 39% discount to fair value. Despite a drop in net income to A$4.3 million from A$11.3 million last year and reduced profit margins from 1.9% to 0.6%, earnings are forecasted to grow significantly at over 31% annually, outpacing the Australian market's growth rate of 12%.
- According our earnings growth report, there's an indication that Temple & Webster Group might be ready to expand.
- Click to explore a detailed breakdown of our findings in Temple & Webster Group's balance sheet health report.
Make It Happen
- Explore the 47 names from our Undervalued ASX Stocks Based On Cash Flows screener here.
- Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
- Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.
Seeking Other Investments?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com